Fingerprint
Dive into the research topics of 'Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease
Alzheimer’s Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, Longitudinal CSF Proteomics Project Team
Research output: Contribution to journal › Article › peer-review